Alzheimer’s Disease Flashcards

1
Q

What is the most common cause of dementia?

A

Alzheimer’s disease is the most common cause of dementia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of dementia

A

Alzheimer’s disease (AD): 50-75%
Vascular dementia (VD): 20%
Dementia with Lewy body (DLB): 15-20%
Frontotemporal dementia (FTD): 2%
Rare causes: Parkinson’s disease dementia (PDD), Huntington’s disease (HD), Prion disease, others.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aetiology of dementia - overview

A

Age: older age is a major risk for AD
Genetics*: most cases of AD are sporadic. Small number of inherited causes exist (<5%, autosomal dominant inheritance). Inherited causes suggested by early-onset disease. Mutations in the amyloid precursor protein (APP) and presenilin genes (PSEN1, PSEN2) have been identified.
Cardiovascular disease: smoking and diabetes increase risk. Exercise decreases risk.
Depression
Low educational attainment
Low social engagement and support
Others: head trauma, learning difficulties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The neurodegeneration in AD is hypothesised secondary to altered … and … protein metabolism.

A

The neurodegeneration in AD is hypothesised secondary to altered amyloid and tau protein metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The two key pathological changes in AD are … plaques and … tangles:

A

Senile plaques (SP): deposits of beta-amyloid (aggregation of protein with a beta-sheet secondary structure). Dense, insoluble. Occur outside of neurons (i.e. extracellular).

Neurofibrillary tangles (NFT): aggregations of hyperphosphorylated tau proteins. Typically occur in areas of the brain involved in memory. Promote neuronal cell death. Form inside neurons (i.e. intracellular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the clinical features of dementia? Specifically, Alzheimer’s?

A

Cognitive impairment: poor memory, disorientation, language problems
Behavioural and psychological symptoms of dementia (BPSD): agitation, depression, sleep cycle disturbance, motor disturbance
Disease-specific features: AD is characterised by early impairment of memory. This manifests as short-term memory loss and difficulty learning new information
Activities of daily living: an increasing reliance on others for assistance, problems with high-level functioning (e.g. work, finance), problems with basic personal care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In dementia patients - A formal mental status examination should be completed using a recognised …

A

Cognitive assessment tool - domains assessed:
Attention and concentration
Recent and remote memory
Language
Praxis: planned motor movement (e.g. perform a task)
Executive function
Visuospatial function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Before diagnosing dementia, it is essential to exclude all alternative causes
What is done first?

A

Referral to a memory clinic - patients here undergo a formal history and examination (including medication review), full complement of baseline investigations inc bloods and neuro imaging to exclude an underlying cause, and a formal cognitive assessment.
During these, the specific type of dementia may become apparent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alzheimer’s disease may become apparent at memory clinic based on the following…

A

lack of other neurological symptoms, absence of major cardiovascular risk factors and predominant impairment in memory, thinking and behaviour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnostic criteria for dementia - 3 key components include

A

Functional ability
Cognitive domains (>2 domains)
Differentials excluded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define mild cognitive impairment

A

This describes cognitive deficits in one or more of the major cognitive domains, but the deficit is insufficient to interfere with independence in daily activities.

Mild cognitive impairment is an increasingly important term because it helps identify patients at risk of progression to dementia. Patients should have regular follow-up and be advised to undertake healthy brain activities (e.g. exercise, socialising).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The main differentials to exclude in a patient with features of dementia are the three ‘D’s’:

A

Depression (and other psychiatric disorders): psychosis can be a feature of dementia.
Drugs: consider drugs with anti-cholinergic effects (e.g. anti-histamines, anti-psychotics, anti-epileptics)
Delirium: acute confusional state. May be prolonged recovery following episode.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bloods to order in suspected dementia patient (8)

A

Full blood count
Erythrocyte sedimentation rate (ESR)
Urea and electrolytes
Bone profile
HbA1c
Liver function tests
Thyroid function tests
Serum B12 and folate levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Overview of management of dementia

A

Assess capacity + advanced care planning
Physical and mental health
Driving - DVLA
Pharmacological management
Non-pharmacological
Managing BPSD
Care plans
End of life care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mild to moderate AD - what pharmacological therapy is indicated?

A

Acetylcholinesterase inhibitors (e.g. donepezil, revastigmine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Moderate to severe AD - what pharmacological therapy is indicated?

A

N-methyl-D-aspartic acid receptor antagonist (e.g. memantine). May be used in combination with acetylcholinesterase inhibitors.

17
Q

… has modest effects in patients with moderate-to-severe AD in terms of reducing functional decline.

A

Memantine has modest effects in patients with moderate-to-severe AD in terms of reducing functional decline.

18
Q

… inhibitors are associated with small improvements in cognition, neuropsychiatric symptoms, and ADLs in patients with mild-to-moderate AD. However, there is conflicting evidence on there impact on long-term outcomes (e.g. need for care home, effect on critical ADLs).

A

Acetylcholinesterase inhibitors are associated with small improvements in cognition, neuropsychiatric symptoms, and ADLs in patients with mild-to-moderate AD. However, there is conflicting evidence on there impact on long-term outcomes (e.g. need for care home, effect on critical ADLs).

19
Q

Alzheimer’s medication options? (3)

A

Donepezil, rivastigmine, memantine